Weight-loss medicines approved in New Zealand, and recommended for funding, but pathway remains unclear

February 25, 2026 News

This is a preview of subscriber content

Subscribe now to continue reading.

The approvals of weight loss therapies illustrate a familiar feature of New Zealand’s medicines system. Regulatory approval can precede public funding by several years, particularly for newer or high-cost treatments. …

Subscribe now to continue reading.

Latest Video

New partnership expands access to care for Australians with rare cancers
May 19, 2026 - Latest News
Sandoz urges faster access as government signals biosimilar consultation
May 19, 2026 - Latest News
Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS
May 20, 2026 - Latest News
Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'
May 19, 2026 - Latest News
Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation
May 19, 2026 - Latest News

Weight-loss medicines approved in New Zealand, and recommended for funding, but pathway remains unclear

This is a preview of subscriber content

Latest Video

Most Read

New partnership expands access to care for Australians with rare cancers

Sandoz urges faster access as government signals biosimilar consultation

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation

New Stories

Australia’s life sciences sector emerges as fast growing, globally connected powerhouse

They used to forecast growth, it was not real and couldn't be used, and it made the program a target for cuts

New report reveals how AI is now deciding which healthcare brands Australians see online

Medicine shortages and workforce gaps threaten the sustainability of Australian care

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Australia bets on translational science to turn discovery into global impact

Sign In

Weight-loss medicines approved in New Zealand, and recommended for funding, but pathway remains unclear

This is a preview of subscriber content

Latest Video

Most Read

New partnership expands access to care for Australians with rare cancers

Sandoz urges faster access as government signals biosimilar consultation

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Perth hosts AusMedtech conference as industry focuses on innovation and commercialisation

Follow Us

New Stories

Australia’s life sciences sector emerges as fast growing, globally connected powerhouse

They used to forecast growth, it was not real and couldn't be used, and it made the program a target for cuts

New report reveals how AI is now deciding which healthcare brands Australians see online

Medicine shortages and workforce gaps threaten the sustainability of Australian care

Sanofi therapy wins Australian registration for non-relapsing secondary progressive MS

Owen Smith: 'We are ready to negotiate. We are ready to be a genuine partner'

Australia bets on translational science to turn discovery into global impact